H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 11.5% of adults in Providence have diagnosed diabetes — 0.5 points below the U.S. 12% figure. Census population 189,692. Rhode Island Medicare wound biologics: National Government Services (NGS) (JK). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Providence clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Providence storefront.
Tendon and Ligament Support Therapy in Providence, RI for clinics & physicians. Biologic therapies for ten… Compliance support & pricing — contact Hawk Medical.
Adult arthritis here is 18.8% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. CDC PLACES (2023, crude) estimates 11.5% of adults in Providence have diagnosed diabetes — 0.5 points below the U.S. 12% figure. Together those PLACES numbers are why a city under 250k still needs separate PRP and CTP protocols. tendon ligament support therapy inventory is national; utilization is JK-local.
National Tendon and Ligament Support Therapy notes (how the product actually works)America’s Health Rankings (BRFSS 2024) only publishes state diabetes as a range nationally (Colorado 8.4% to West Virginia 18.4%). For Providence we use CDC PLACES instead of interpolating a fake city rate from that range. CDC PLACES (2023, crude) estimates 11.5% of adults in Providence have diagnosed diabetes — 0.5 points below the U.S. 12% figure.
Vendor consolidation is boring on purpose: one account, IFUs filed, JK articles mapped. 14.6% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Pricing scripts have to match that mix. We will help write them. We will not book your patients.
CDC PLACES (2023, crude prevalence) estimates 11.5% of adults — 0.5 points below the U.S. 12% figure. Obesity is 34.4%; arthritis is 18.8%. That is place-level BRFSS modeling, not a clinic census and not a Providence trial.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including Rhode Island.
Yes. Tissue products come from FDA-registered banks with donor screening and lot traceability. Your receiving SOP should file IFU, lot, and indication with the chart. That packet is what JK reviewers and surveyors expect — not a brochure.
Regulatory lane, storage, and JK coding. Amniotic products used as 361 HCT/Ps are not “better gauze.” Match wound stage and coverage article before you convert the cart.
Ask for the IFU, the lot-traceability packet, and the National Government Services (NGS) article IDs for the codes you actually bill. If the sales sheet cannot produce those, do not put it in a Providence fridge. That is how an account with us starts.
Contact us to learn how Hawk Medical supports practices in Providence, RI.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Providence is JK geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Providence — 0.5 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Rhode Island Part B wound biologics follow this contractor (siblings: CT, MA, ME, NH, NY, VT). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Providence. Useful for joint-program math; still needs a diagnosis and privileging.
No Providence storefront. Joe Bradley is an active practice owner. tendon ligament support therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.